Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer.

导出 OA

翻译打印收藏纠错

作者： Kiranj,Chaudagar ^[1] ; Hanna M,Hieromnimon ^[1] ; Rimpi,Khurana ^[2] ; Brian,Labadie ^[1] ; Taghreed,Hirz ^[3] ; Shenglin,Mei ^[4] ; Raisa,Hasan ^[5] ; Jordan,Shafran ^[3] ; Anne,Kelley ^[6] ; Eva,Apostolov ^[7] ; Ghamdan,Al-Eryani ^[8] ; Kate,Harvey ^[1] ; Srikrishnan,Rameshbabu ^[1] ; Mayme,Loyd ^[7] ; Kaela,Bynoe ^[8] ; Catherine,Drovetsky ^[7] ; Ani,Solanki ^[8] ; Erica,Markiewicz ^[7] ; Marta,Zamora ^[1] ; Xiaobing,Fan ^[1] ; Stephan,Schürer ^[1] ; Alex,Swarbrick ^[1] ; David B,Sykes ^[9] ; Akash,Patnaik ^[10]

作者单位： Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois. ^[1] Department of Pharmacology, Miller School of Medicine, University of Miami, Miami, Florida. ^[2] Center for Regenerative Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts. ^[3] Harvard Stem Cell Institute, Cambridge, Massachusetts. ^[4] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts. ^[5] Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts. ^[6] Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia. ^[7] St Vincent's Clinical School, Faculty of Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia. ^[8] Animal Resource Center, University of Chicago, Chicago, Illinois. ^[9] Department of Radiology, University of Chicago, Chicago, Illinois. ^[10] Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida. ^[11]